Uniphar (LON:UPR) Shares Down 0.9% – Time to Sell?

Shares of Uniphar plc (LON:UPR) fell 0.9% on Friday . The company traded as low as GBX 318 and last traded at GBX 318. 18,406 shares changed hands during mid-day trading, a decline of 59% from the average session volume of 45,037 shares. The stock had previously closed at GBX 321.

Wall Street Analyst Weigh In

Separately, Royal Bank Of Canada boosted their target price on shares of Uniphar from GBX 470 to GBX 480 and gave the stock an “outperform” rating in a report on Tuesday, September 9th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of GBX 427.50.

Uniphar Trading Down 0.9%

The company has a fifty day simple moving average of GBX 333.05 and a 200-day simple moving average of GBX 329.88. The stock has a market cap of £825.45 million, a price-to-earnings ratio of 12.98 and a beta of 0.75. The company has a current ratio of 0.90, a quick ratio of 0.60 and a debt-to-equity ratio of 119.48.

About Uniphar

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.